Michael Weinblatt
Overview
Explore the profile of Michael Weinblatt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shimizu M, Paudel M, Shadick N, Weinblatt M, Solomon D
Semin Arthritis Rheum
. 2025 Feb;
71:152635.
PMID: 39892288
Objectives: The association between age of rheumatoid arthritis (RA) onset and joint erosions remains unclear. We investigated the effects of age of RA onset on incident joint erosion and the...
2.
Smolen J, Taylor P, Tanaka Y, Takeuchi T, Hashimoto M, Cara C, et al.
Rheumatology (Oxford)
. 2024 Sep;
63(11):3015-3024.
PMID: 39222436
Objectives: To assess the impact of baseline RF level on drug concentrations and efficacy of certolizumab pegol [CZP; TNF inhibitor (TNFi) without a crystallizable fragment (Fc)] and adalimumab (ADA; Fc-containing...
3.
Shadick N, Hagino O, Praestgaard A, Fiore S, Weinblatt M, Burmester G
Arthritis Res Ther
. 2023 May;
25(1):88.
PMID: 37237405
Background: To evaluate baseline hemoglobin (Hb) and radiographic progression over time in patients enrolled in the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) registry. Methods: The BRASS is a...
4.
Maica G, Iannaccone C, Feathers V, Frits M, Bykerk V, Bingham 3rd C, et al.
J Rheumatol
. 2023 Feb;
50(7):889-894.
PMID: 36725063
Objective: Recently, there has been consensus on domains that constitute flares in rheumatoid arthritis (RA); however, variations in patients' flare descriptions continue to be observed. This study evaluates how demographic...
5.
Taylor P, Chen Y, Pope J, Weinblatt M, Mysler E, Rubbert-Roth A, et al.
Rheumatol Ther
. 2023 Jan;
10(2):463-476.
PMID: 36662442
Introduction: We sought to identify and compare treatment response groups based on individual patient responses (rather than group mean response) over time on the Clinical Disease Activity Index (CDAI) for...
6.
Pierson S, Shenoy S, Oromendia A, Gorzewski A, Langan Pai R, Nabel C, et al.
Blood Adv
. 2021 Aug;
5(17):3445-3456.
PMID: 34438448
Idiopathic multicentric Castleman disease (iMCD) is a poorly understood hematologic disorder involving cytokine-induced polyclonal lymphoproliferation, systemic inflammation, and potentially fatal multiorgan failure. Although the etiology of iMCD is unknown, interleukin-6...
7.
Weber B, He Z, Yang N, Playford M, Weisenfeld D, Iannaccone C, et al.
Arthritis Rheumatol
. 2021 Feb;
73(6):970-979.
PMID: 33615723
Objective: Patients with rheumatoid arthritis (RA) are 1.5 times more likely to develop cardiovascular disease (CVD) attributed to chronic inflammation. A decrease in inflammation in patients with RA is associated...
8.
Curtis J, Weinblatt M, Saag K, Bykerk V, Furst D, Fiore S, et al.
Arthritis Care Res (Hoboken)
. 2020 Oct;
73(4):471-480.
PMID: 33002337
Objective: To use unbiased, data-driven, principal component (PC) and cluster analysis to identify patient phenotypes of rheumatoid arthritis (RA) that might exhibit distinct trajectories of disease progression, response to treatment,...
9.
Degboe Y, Schiff M, Weinblatt M, Fleischmann R, Ahmad H, Constantin A
J Clin Med
. 2020 Jul;
9(6).
PMID: 32604962
To date, the impact of background glucocorticoids (GC) on the efficacy and safety of abatacept or adalimumab in patients with active rheumatoid arthritis (RA) is not clearly established. This post...
10.
Fleischmann R, Weinblatt M, Ahmad H, Maldonado M, Alemao E, Ye J, et al.
Rheumatol Ther
. 2019 Oct;
6(4):559-571.
PMID: 31642045
Introduction: Patients with rheumatoid arthritis (RA) with poor prognostic factors, such as seropositivity for anti-citrullinated protein antibodies and early erosions, may benefit from early intensive treatment. However, information to guide...